Skip to main content
. 2020 May 13;12(5):1219. doi: 10.3390/cancers12051219

Figure 2.

Figure 2

Tissue and plasma RNA fusion landscape. (A) Oncoprint depicting tumor tissue and plasma RNA fusions in the study cohort (GBM patients, n = 9, left; healthy controls, n = 10, right). (B) Summary of fusions detected by the Massachusetts General Hospital (MGH) Solid Fusion Assay of tumor tissue, RNA-seq of the tumor tissue and plasma of GBM patients and RNA-seq of the plasma of healthy controls.